http://www.abbs.info E-mail:[email protected]
ISSN 0582-9879 Acta Biochim et Biophysica Sinica 2004, 36(6):437-442 CN
31-1300/Q
Fusion Protein of Interleukin 4 and Diphtherial Toxin with High Cytotoxicity to Cancer Cells
Yu-Jian ZHANG, Xiao-Bo HU, Su-Xia LI1, Li-Ping TIAN, Sheng-Li YANG, and Yi GONG*
Research Center of Biotechnology, Shanghai
Institutes for Biological Sciences,Chinese Academy of Sciences, Graduate School
of the Chinese Academy of Sciences, Shanghai 200233, China;
1State Key Laboratory of Bioreactor
Engineering, East China University of Science and Technology, Shanghai 200237,
China
Abstract Receptor of human
interleukin 4 (hIL4R) has been found to be present on many types of cancer, so
it may be a good target for cancer therapy. Here, fusion toxin gene DT4H
has been constructed by fusing DNA sequence encoding the first 389 amino acids
of diphtherial toxin (DT), which can not bind its own receptor, to human
interleukin 4 (hIL4) gene. In order to improve the affinity of fusion toxin for
hIL4R, a circularly permuted form of hIL4 (cpIL4) was used. The fusion gene was
expressed in Escherichia coli where the fusion toxin DT4H was highly
expressed. Purified DT4H was very cytotoxic to cancer cell line U251 cells, and
moderate cytotoxic to HepG2 and MCF-7 cells. SGC-7901 cells were insensitive to
it. The cytotoxic action of DT4H was specific because it was blocked by excess
hIL4. These results suggest that DT4H may be a useful agent in the treatment of
certain malignancies.
Key words fusion toxin; diphtherial toxin; cancer therapy; interleukin 4; IL-4 receptor
-----------------
Received: February 9, 2004 Accepted: March 3, 2004
*Corresponding author: Tel, 86-21-54971069; Fax, 86-21-64700244; E-mail, [email protected]